Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC H-Glu(OtBu)-OtBu hydrochloride | 32677-01-3 | 98.0% | 295.80 | 500 G
SDP

Catalog No. 5000401201
Encompass_Preferred

H-Glu(OtBu)-OtBu hydrochloride is a key intermediate utilized in the synthesis of prostate-specific membrane antigen (PSMA) targeting probes. This compound has the ability to reduce nonspecific background binding through negatively charged linkers, thereby improving tumor/background contrast. It is also applicable in prostate cancer PET/SPECT imaging studies.

  • Key intermediate in PSMA targeting probe synthesis.
  • Reduces nonspecific background binding.
  • Improves tumor/background contrast.
  • Applicable in prostate cancer PET/SPECT imaging studies.
  • Can be used to synthesize PSMA probe 5 for tumor imaging.

Catalog No. 50-004-01201 Supplier Medchemexpress LLC Supplier No. HY20167A500G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

H-Glu(OtBu)-OtBu hydrochloride is a key intermediate utilized in the synthesis of prostate-specific membrane antigen (PSMA) targeting probes. This compound has the ability to reduce nonspecific background binding through negatively charged linkers, thereby improving tumor/background contrast. It is also applicable in prostate cancer PET/SPECT imaging studies.

  • Key intermediate in PSMA targeting probe synthesis.
  • Reduces nonspecific background binding.
  • Improves tumor/background contrast.
  • Applicable in prostate cancer PET/SPECT imaging studies.
  • Can be used to synthesize PSMA probe 5 for tumor imaging.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.